Houlihan Lokey (HLI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Houlihan Lokey (HLI) reported $659.45 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 14.7%. EPS of $1.84 for the same period compares to $1.46 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $654.33 million, representing a surprise of +0.78%. The company delivered an EPS surprise of +8.88%, with the consensus EPS estimate being $1.69.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Houlihan Lokey performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Number of managing directors - Corporate Finance: 242 versus the two-analyst average estimate of 251.Number of managing directors - Financial and Valuation Advisory: 45 versus the two-analyst average estimate of 45.Number of managing directors - Financial Restructuring: 58 versus 59 estimated by two analysts on average.Revenue- Corporate Finance: $438.66 million versus $437.22 million estimated by three analysts on average.Revenue- Financial Advisory Services: $86.99 million versus $84.42 million estimated by three analysts on average.Revenue- Financial Restructuring: $133.8 million versus the three-analyst average estimate of $132.69 million.View all Key Company Metrics for Houlihan Lokey here>>>Shares of Houlihan Lokey have returned -1.2% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Houlihan Lokey, Inc. (HLI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks